[

    ', 

	', 
        ', 
            ', 
                ', 
                    ', 
                        ', 
                            ', 
                        ', 
                    ', 
                    
                    ', 
                        ', 
                    ', 
                        
                    ', 
                        ', 
                            ', Corporate Overview', 
                            ', 
                                ', 
                                    ', 
                                        ', 
                                            ', 
                                                ', Glenmark at a Glance', 
												', Our Global Assets', 
												', Our Strategic Priorities', 
												', u"Chairman's Message", 
												', Board of Directors', 
                                            ', 
                                            ', 
                                                ', Committed to Perform', 
												', Through Innovation', 
                                                ', Through Global Expertise', 
                                                ', Through a Spirit of Excellence', 
                                                ', Corporate Responsibility', 
                                            ', 
                                            ', 
												', Our People', 
												', Key Financials', 
												', Corporate Information', 
                                            ', 
                                        ', 
                                    ', 
                                ', 
                            ', 
                        ', 
                        ', 
                            ', Statutory Reports', 
                            ', 
                                ', 
                                    ', 
                                        ', 
                                            ', 
                                            	', Management Discussion & Analysis', 
                                            ', 
                                            ', 
                                				', Profile of Directors', 
                                            ', 
                                            ', 
                                				', u"Board's Report and Relevant Annexures", 
                                            ', 
                                            ', 
                                				', Report on Corporate Governance', 
											', 
                                        ', 
                                    ', 
                                ', 
                            ', 
                        ', 
                        ', 
                            ', Financial Statements', 
                            ', 
                                ', 
                                    ', 
                                        ', 
											', 
                                            	', Standalone', 
                                                ', u"Standalone Auditor's Report", 
												', Standalone Balance Sheet', 
												', Standalone Statement of Profit & Loss', 
												', Standalone Cash Flow Statement', 
												', Standalone Notes to Financial Statements', 
                                            ', 
                                            ', 
                                            	', Consolidated', 
                                            	', 
                                                    ', u"Consolidated Auditor's Report (IFRS)", 
                                                    ', Consolidated Statement of Financial Position (IFRS)', 
                                                    ', Consolidated Statement of Comprehensive Income (IFRS)', 
                                                    ', u"Consolidated Statement of Changes in Shareholder's Equity (IFRS)", 
                                                    ', Consolidated Statement of Cash Flow (IFRS)', 
                                                ', 
                                                ', 
                                                	', Notes to Consolidated Financial Statements (IFRS)', 
                                                    ', u"Consolidated Auditor's Report (IGAAP)", 
                                                    ', Consolidated Balance Sheet (IGAAP)', 
                                                    ', Consolidated Statement of Profit & Loss (IGAAP)', 
                                                    ', Consolidated Cash Flow Statement (IGAAP)', 
                                                    ', Consolidated Notes to Financial Statements (IGAAP)', 
                                                ', 
											', 
                                        ', 
                                    ', 
                                ', 
                            ', 
                        ', 
                        ', Downloads', 
                    ', 
                ', 

			', 
                ', 
                    ', 
                        ', 
                            ', 
                        ', 
                    ', 

                    ', 
                        ', Men, 
                        ', 
                        ', 
                        ', 
                    ', 

                    ', 
                        ', 
                    ', 

                    ', 
                        ', 
                            ', 
                        ', 
                        ', Corporate Overview', 
                            ', 
                                ', Glenmark at a Glance', 
                                ', Our Global Assets', 
                                ', Our Strategic Priorities', 
                                ', u"Chairman's Message", 
                                ', Board of Directors', 
                                ', Committed to Perform', 
                                ', Through Innovation', 
                                ', Through Global Expertise', 
                                ', Through a Spirit of Excellence', 
                                ', Corporate Responsibility', 
                                ', Our People', 
                                ', Key Financials', 
                                ', Corporate Information', 
                            ', 
                        ', 
                        ', Statutory Reports', 
                            ', 
                                ', Management Discussion & Analysis', 
                                ', Profile of Directors', 
                                ', u"Board's Report and Relevant Annexures", 
                                ', Report on Corporate Governance', 
                            ', 
                        ', 
                        ', Financial Statements', 
                            ', 
                            	', Standalone', 
                                ', u"Standalone Auditor's Report", 
                                ', Standalone Balance Sheet', 
                                ', Standalone Statement of Profit & Loss', 
                                ', Standalone Cash Flow Statement', 
                                ', Standalone Notes to Financial Statements', 
                                ', Consolidated', 
                                ', u"Consolidated Auditor's Report (IFRS)", 
                                ', Consolidated Statement of Financial Position (IFRS)', 
                                ', Consolidated Statement of Comprehensive Income (IFRS)', 
                                ', u"Consolidated Statement of Changes in Shareholder's Equity (IFRS)", 
                                ', Consolidated Statement of Cash Flow (IFRS)', 
                                ', Notes to Consolidated Financial Statements (IFRS)', 
                                ', u"Consolidated Auditor's Report (IGAAP)", 
                                ', Consolidated Balance Sheet (IGAAP)', 
                                ', Consolidated Statement of Profit & Loss (IGAAP)', 
                                ', Consolidated Cash Flow Statement (IGAAP)', 
                                ', Consolidated Notes to Financial Statements (IGAAP)', 
                            ', 
                        ', 
                        ', Downloads', 
                    ', 
                ', 
            ', 
            ', 
        ', 

	', 
        ', 
            ', 
                ', 
                   ', 
', 
                        ', u"Board's Report and Relevant Annexures", 
', 
                    ', 
                    ', 
                        ', 
                            ', You are here: ',  ', Statutory Reports', 
', u"
                            Board's Report and Relevant Annexures
", 
                        ', 
                    ', 
                ', 
            ', 
        ', 
        
	', 
        ', 
            ', 
                ', 
                    ', 
',  
                                    ', 
                                        ', 
                                            ', Your Directors have pleasure in presenting their 38th Annual Report and Audited Accounts of the Company for the year ended 31 March 2016.', 
                                            ', FINANCIAL RESULTS', 
                                            ', 
                                                ', 
                                            ', 
                                            ', The Company has not transferred any amount out of the profit of the year to the General Reserves.', 
                                            
                                            ', DIVIDEND', 
                                            ', Your Directors recommend a Dividend of 200% (', Rs.', 2 per equity share of ', Rs.', 1 each) to be appropriated from the profits of the year 2015 - 2016 subject to the approval of the shareholders at the ensuing Annual General Meeting. The dividend will be paid in compliance with applicable regulations. The dividend, if approved, will result in an outflow of ', Rs.', 679.20 million (including dividend tax).', 
                                            
                                            ', RESULTS OF OPERATIONS', 
                                            ', On Standalone basis the Company achieved gross revenue of  ', Rs.', 62,307.81 million and the Standalone operating profit before finance costs, depreciation & tax was ', Rs.', 18,729.35 million as  compared to ', Rs.', 13,811.94 million in the previous year.',  On Consolidated basis the Company achieved a gross revenue of ', Rs.', 75,799.99 million and the Consolidated operating profit before finance costs, depreciation & tax was ', Rs.', 14,538.58 million  as compared to ', Rs.', 10,341.02 million in the previous year.', 
                                            
                                            ', CORPORATE GOVERNANCE', u"
                                            Your Company believes Corporate Governance is at the core of stakeholder satisfaction. Your Company's governance practices are described separately in this Annual Report. Your Company  has obtained a certification from Mr. Surjan Singh Rauthan, Partner of M/s. MARK & Associates Company Secretaries LLP, on our compliance with Listing Agreement read with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 with Indian Stock Exchanges. This certificate is attached to the Report on Corporate Governance.", 
                                            
                                            ', DIRECTORS', 
                                            Mr. Rajesh Desai retires by rotation at ensuing Annual General Meeting and being eligible offers himself for re-appointment. The Board of Directors have recommended his re-appointment for  consideration of the Shareholders. The term of appointment of Mr. Rajesh Desai as Whole-time Director ends on 8 November 2016 on the recommendation of the Nomination  and Remuneration Committee, the Board of Directors of the Company at its meeting held on 12 May 2016 has re-appointed Mr. Rajesh Desai as Whole-time Director designated  as Executive Director for the further period of one year w.e.f. 9 November 2016 subject to approval of shareholders at ensuing  Annual General Meeting of the Company.',  All Independent Directors have declared that they meet the  criteria of Independence as laid down under Section 149(6) of the Companies Act, 2013 and Regulation 16(b) of SEBI (Listing  Obligations and Disclosure Requirements) Regulations, 2015.', Mr. N. B. Desai resigned as a Board Member w.e.f. 1 June 2015 due to his old age and health conditions. The Board placed on  record its sincere appreciation for his valuable guidance and  contribution during his tenure as a Board Member.',  The Board of Directors on the recommendation of the  Nomination & Remuneration Committee had appointed Mr. Milind Sarwate, as an Additional Director of the Company  w.e.f. 29 October 2015.',  In accordance with Section 161 of the Companies Act, 2013, Mr. Milind Sarwate holds office upto the date of the ensuing Annual General Meeting of the Company and being eligible offers his candidature for appointment as Director. The Company has received a notice from a member proposing his appointment as a Director of the Company. His appointment  will be in the category of Non-Executive Independent Director for a term of five years i.e. upto 28 October 2020 and not liable  to retire by rotation. A resolution seeking your approval for his appointment as Director in the category of Non-Executive  Independent Director has been included at Item no. 7 in the Notice of the forthcoming Annual General Meeting of the Company.', 
                                            
                                            ', SUBSIDIARIES, JOINT VENTURES AND ASSOCIATE COMPANIES', 
                                            ', As per Section 129(3) of the Companies Act, 2013 and SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 the Consolidated Financial Statements of the Company and all its subsidiaries for the year ended 31 March 2016 prepared in accordance with International Financial Reporting Standards and Indian Generally Accepted Accounting Principles as permitted by SEBI forms a part of the Annual Report. Further  in terms of the first proviso of Section 129(3) of the Act and Rules 5 and 8(1) of the Companies (Accounts) Rules, 2014, a statement containing the salient features, performance and financial position of the subsidiaries in the prescribed Form  AOC-1 is appended herewith as Annexure I to the Report.', 
                                            
                                            ', During the F.Y. 2015-16', 
                                            ', 
                                                ', Three new step-down subsidiaries were incorporated which are as under:
                                                    ', 
                                                        ', Viso Farmaceutica S.L., Spain', 
                                                        ', Glenmark Specialty S.A.; Switzerland', 
                                                        ', Glenmark Pharmaceuticals Distribution S.R.O.; Czech Republic', 
                                                    ', 
                                                ', 
                                                ', Glenmark Generics Finance S.A., Switzerland got absorbed by way of a side step merger with Glenmark Holding S.A., Switzerland.', 
                                            ', 
                                            ', u"The policy for determining material subsidiaries may be accessed on the Company's website at the link:",  ', http://www.glenmarkpharma.com/UITemplate/PDF/Policy_on_Material_Subsidiary.pdf ', u"The Audited Accounts of the subsidiaries together with its Board's Report and Auditors' Report are available for inspection  of members on any working day at the Corporate Office of the Company between 11 a.m. to 1 p.m.", 
                                            
                                            ', MANAGEMENT DISCUSSION AND ANALYSIS REPORT', 
                                            
                                            ', The Management Discussion and Analysis Report on the operations of the Company, as required under SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015  with the Stock Exchanges is provided in a separate section and forms a part of this report.', 
                                            
                                            ', PARTICULARS OF CONTRACT OR ARRANGEMENTS WITH RELATED PARTIES', 
                                            ', Particulars of contracts or arrangements with related parties referred to in Section 188(1) of the Companies Act, 2013 in the prescribed Form AOC-2, is appended as Annexure II to this report.', 
                                            ', The Company avails professional advisory services from the following Companies/firms in which the Directors are interested:', 						 
                                            ', 
                                                ', Trilegal, a firm in which one of the Directors of the Company is a partner and the Company has paid to them ', Rs.', 1.33 million for availing professional services;', 
                                            ', 
            
                                            ', u"The policy on materiality of related party transactions and dealing with related party transactions may be accessed on the company's website at the link:",  ', http://www.glenmarkpharma.com/UITemplate/PDF/Policy_on_ Related_Party_Transactions_and_its_Materiality_Glenmark.pdf', 
                                            
                                            ', u"AUDITORS AND AUDITORS' REPORT", 
                                            ', Statutory Auditors', 
                                            ', The Auditors, M/s. Walker Chandiok & Co LLP, Chartered Accountants (Firm Registration No. 001076N), were appointed as Auditors in the last (37th) Annual General Meeting for a term of five years i.e., till the conclusion of the 42nd Annual General  Meeting of the Company which was subject to ratification at every Annual General Meeting till the conclusion of 41st Annual General Meeting. A resolution seeking your ratification has been included as Item No. 5 of the Notice convening the Annual General Meeting.', 
                                            ', The Auditors Report does not contain any qualification, reservation or adverse remarks.', 
                                            ', Cost Auditors', 
                                            ', Your Directors, on the recommendation of the Audit Committee  have re-appointed Sevekari, Khare & Associates (Registration No. 000084) as Cost Auditors to audit the cost records of the Company for the Financial Year 2016-2017 at a remuneration of ', Rs.', 1.27 million.', 
                                            
                                            ', Pursuant to Section 148 of the Companies Act, 2013 read with The Companies (Cost Records and Audit) Rules 2014, as amended from time to time, the cost audit records maintained by the Company are required to be audited. In terms of the provisions of the Companies Act, 2013, the remuneration  payable to them is required to be ratified by the Shareholders at the ensuing Annual General Meeting and accordingly, a resolution seeking your ratification has been included as Item No. 6 of the Notice convening the Annual General Meeting. The  Cost Audit Report for the Financial Year 2014-15 has been filed on 29 September 2015.', 
                                            
                                            ', Secretarial Auditor', 
                                            ', The Board had appointed M/s. MARK & Associates Company Secretaries LLP, to conduct Secretarial Audit for the Financial Year 2015-16. The Secretarial Audit Report for the financial year  ended 31 March 2016 is appended herewith as Annexure III to this report. The Secretarial Audit Report does not contain any qualification, reservation or adverse remarks.', 
                                            
                                            ', CHANGES IN CAPITAL STRUCTURE', 
                                            ', Issue of shares on exercise of Employees Stock Options:', 
                                            During the year, we allotted 45,800 Equity Shares of ', Rs.', 1/- each (on pari-passu basis) on the exercise of stock options by the eligible employees of the Company and its subsidiaries under  the 2003 Employee Stock Option Scheme. ', Issue of Shares Pursuant to Merger',  ', 17,803 equity shares of the face value of ', Rs.', 1 each fully paid-up issued to the public shareholders of Glenmark Generics Limited  (GGL) pursuant to the Merger of GGL with the Company.',  ', Issue of Shares on Preferential Basis',  The Company had issued 1,08,00,000 equity shares of the face value of ', Rs.', 1 each fully paid-up to Aranda Investments (Mauritius) Pte Ltd. on a preferential basis pursuant to the provisions of Section 62 of Companies Act, 2013 and other applicable provisions, if any.', 
                                            ', As a result of the above, the outstanding issued, subscribed and paid-up equity shares increased from 27,12,94,553 to 28,21,58,156 shares as at 31 March 2016.', 
                                            
                                            ', Employee Stock Option Scheme ', The information in compliance with Regulation 14 of the Securities and Exchange Board of India (Share Base Employee Benefits) Regulations, 2014 as amended are appended herewith as Annexure IV to this Report.', 
                                            ', No employee was issued Stock Options during the year. As on 31 March 2016, 34,500 options were cancelled and 84,500 options are outstanding. ', 
                                            ', On exercising the convertible options so granted, the paid-up equity share capital of the Company will increase by a like number of shares.', 
                                            ',  Further, the Board of Directors of the Company at its meeting held on 12 May 2016 has approved, subject to the  shareholders' approval and other necessary approvals, a new Scheme 'Glenmark Pharmaceuticals Limited - Employee Stock Options Scheme 2016' ("ESOS 2016") under the Securities  and Exchange Board of India (Share Based Employee Benefits) Regulations, 2014 and other applicable laws, Regulations, etc. for the purposes of granting options to the permanent employees of the Company and its subsidiaries, as applicable. Approval of the shareholders in this regard is being sought at the ensuing Annual General Meeting of the Company.', 
                                                    ', 
                                                 ', 
                                                                            
                                            	 ', 
                                                    ', 
                                                    ', 1', 
                                                    ', 2', 
                                                    ', 3', 
                                                    ', 4', 
                                                    ', 5', 
                                                    ', 6', 
                                                    ', 7', 
                                                    ', 8', 
                                                    ', 9', 
                                                    ', 
                                                  ',                                     
', 
                    ', 
                    
                    ', 
                        ', 
', 
                            ', Statutory Reports', 
', 
                        ', 
                        ', 
', 
                            ', Management Discussion & Analysis', 
                            ', Profile of Directors', 
                            ', u"Board's Report and Relevant Annexures", 
                            ', Report on Corporate Governance', 
', 
                        ', 
                    ', 
                ', 
            ', 
        ', 

        ', 
            ', 
                ', 
                     ', 
                        ', 
                            ', © Copyright 2016 Glenmark', 
                        ', 
                    	', 
                            ', Design by ', Elixir Integrated Brandcomm Pvt Ltd', .', 
                        ', 
                    ', 
                ', 
            ', 
        ', 
        
        ', 
            ', 
        ', 

        ', 
        ', 
        ', 
        ', 
        ', 
        ', 
        ', 
        ', 
        ', 
       
        ', 
    ', 

'][

    ', 

	', 
        ', 
            ', 
                ', 
                    ', 
                        ', 
                            ', 
                        ', 
                    ', 
                    
                    ', 
                        ', 
                    ', 
                        
                    ', 
                        ', 
                            ', Corporate Overview', 
                            ', 
                                ', 
                                    ', 
                                        ', 
                                            ', 
                                                ', Glenmark at a Glance', 
												', Our Global Assets', 
												', Our Strategic Priorities', 
												', u"Chairman's Message", 
												', Board of Directors', 
                                            ', 
                                            ', 
                                                ', Committed to Perform', 
												', Through Innovation', 
                                                ', Through Global Expertise', 
                                                ', Through a Spirit of Excellence', 
                                                ', Corporate Responsibility', 
                                            ', 
                                            ', 
												', Our People', 
												', Key Financials', 
												', Corporate Information', 
                                            ', 
                                        ', 
                                    ', 
                                ', 
                            ', 
                        ', 
                        ', 
                            ', Statutory Reports', 
                            ', 
                                ', 
                                    ', 
                                        ', 
                                            ', 
                                            	', Management Discussion & Analysis', 
                                            ', 
                                            ', 
                                				', Profile of Directors', 
                                            ', 
                                            ', 
                                				', u"Board's Report and Relevant Annexures", 
                                            ', 
                                            ', 
                                				', Report on Corporate Governance', 
											', 
                                        ', 
                                    ', 
                                ', 
                            ', 
                        ', 
                        ', 
                            ', Financial Statements', 
                            ', 
                                ', 
                                    ', 
                                        ', 
											', 
                                            	', Standalone', 
                                                ', u"Standalone Auditor's Report", 
												', Standalone Balance Sheet', 
												', Standalone Statement of Profit & Loss', 
												', Standalone Cash Flow Statement', 
												', Standalone Notes to Financial Statements', 
                                            ', 
                                            ', 
                                            	', Consolidated', 
                                            	', 
                                                    ', u"Consolidated Auditor's Report (IFRS)", 
                                                    ', Consolidated Statement of Financial Position (IFRS)', 
                                                    ', Consolidated Statement of Comprehensive Income (IFRS)', 
                                                    ', u"Consolidated Statement of Changes in Shareholder's Equity (IFRS)", 
                                                    ', Consolidated Statement of Cash Flow (IFRS)', 
                                                ', 
                                                ', 
                                                	', Notes to Consolidated Financial Statements (IFRS)', 
                                                    ', u"Consolidated Auditor's Report (IGAAP)", 
                                                    ', Consolidated Balance Sheet (IGAAP)', 
                                                    ', Consolidated Statement of Profit & Loss (IGAAP)', 
                                                    ', Consolidated Cash Flow Statement (IGAAP)', 
                                                    ', Consolidated Notes to Financial Statements (IGAAP)', 
                                                ', 
											', 
                                        ', 
                                    ', 
                                ', 
                            ', 
                        ', 
                        ', Downloads', 
                    ', 
                ', 

			', 
                ', 
                    ', 
                        ', 
                            ', 
                        ', 
                    ', 

                    ', 
                        ', Men, 
                        ', 
                        ', 
                        ', 
                    ', 

                    ', 
                        ', 
                    ', 

                    ', 
                        ', 
                            ', 
                        ', 
                        ', Corporate Overview', 
                            ', 
                                ', Glenmark at a Glance', 
                                ', Our Global Assets', 
                                ', Our Strategic Priorities', 
                                ', u"Chairman's Message", 
                                ', Board of Directors', 
                                ', Committed to Perform', 
                                ', Through Innovation', 
                                ', Through Global Expertise', 
                                ', Through a Spirit of Excellence', 
                                ', Corporate Responsibility', 
                                ', Our People', 
                                ', Key Financials', 
                                ', Corporate Information', 
                            ', 
                        ', 
                        ', Statutory Reports', 
                            ', 
                                ', Management Discussion & Analysis', 
                                ', Profile of Directors', 
                                ', u"Board's Report and Relevant Annexures", 
                                ', Report on Corporate Governance', 
                            ', 
                        ', 
                        ', Financial Statements', 
                            ', 
                            	', Standalone', 
                                ', u"Standalone Auditor's Report", 
                                ', Standalone Balance Sheet', 
                                ', Standalone Statement of Profit & Loss', 
                                ', Standalone Cash Flow Statement', 
                                ', Standalone Notes to Financial Statements', 
                                ', Consolidated', 
                                ', u"Consolidated Auditor's Report (IFRS)", 
                                ', Consolidated Statement of Financial Position (IFRS)', 
                                ', Consolidated Statement of Comprehensive Income (IFRS)', 
                                ', u"Consolidated Statement of Changes in Shareholder's Equity (IFRS)", 
                                ', Consolidated Statement of Cash Flow (IFRS)', 
                                ', Notes to Consolidated Financial Statements (IFRS)', 
                                ', u"Consolidated Auditor's Report (IGAAP)", 
                                ', Consolidated Balance Sheet (IGAAP)', 
                                ', Consolidated Statement of Profit & Loss (IGAAP)', 
                                ', Consolidated Cash Flow Statement (IGAAP)', 
                                ', Consolidated Notes to Financial Statements (IGAAP)', 
                            ', 
                        ', 
                        ', Downloads', 
                    ', 
                ', 
            ', 
            ', 
        ', 

	', 
        ', 
            ', 
                ', 
                   ', 
', 
                        ', u"Board's Report and Relevant Annexures", 
', 
                    ', 
                    ', 
                        ', 
                            ', You are here: ',  ', Statutory Reports', 
', u"
                            Board's Report and Relevant Annexures
", 
                        ', 
                    ', 
                ', 
            ', 
        ', 
        
	', 
        ', 
            ', 
                ', 
                    ', 
',  
                                    ', 
                                        ', 
                                            ', Your Directors have pleasure in presenting their 38th Annual Report and Audited Accounts of the Company for the year ended 31 March 2016.', 
                                            ', FINANCIAL RESULTS', 
                                            ', 
                                                ', 
                                            ', 
                                            ', The Company has not transferred any amount out of the profit of the year to the General Reserves.', 
                                            
                                            ', DIVIDEND', 
                                            ', Your Directors recommend a Dividend of 200% (', Rs.', 2 per equity share of ', Rs.', 1 each) to be appropriated from the profits of the year 2015 - 2016 subject to the approval of the shareholders at the ensuing Annual General Meeting. The dividend will be paid in compliance with applicable regulations. The dividend, if approved, will result in an outflow of ', Rs.', 679.20 million (including dividend tax).', 
                                            
                                            ', RESULTS OF OPERATIONS', 
                                            ', On Standalone basis the Company achieved gross revenue of  ', Rs.', 62,307.81 million and the Standalone operating profit before finance costs, depreciation & tax was ', Rs.', 18,729.35 million as  compared to ', Rs.', 13,811.94 million in the previous year.',  On Consolidated basis the Company achieved a gross revenue of ', Rs.', 75,799.99 million and the Consolidated operating profit before finance costs, depreciation & tax was ', Rs.', 14,538.58 million  as compared to ', Rs.', 10,341.02 million in the previous year.', 
                                            
                                            ', CORPORATE GOVERNANCE', u"
                                            Your Company believes Corporate Governance is at the core of stakeholder satisfaction. Your Company's governance practices are described separately in this Annual Report. Your Company  has obtained a certification from Mr. Surjan Singh Rauthan, Partner of M/s. MARK & Associates Company Secretaries LLP, on our compliance with Listing Agreement read with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 with Indian Stock Exchanges. This certificate is attached to the Report on Corporate Governance.", 
                                            
                                            ', DIRECTORS', 
                                            Mr. Rajesh Desai retires by rotation at ensuing Annual General Meeting and being eligible offers himself for re-appointment. The Board of Directors have recommended his re-appointment for  consideration of the Shareholders. The term of appointment of Mr. Rajesh Desai as Whole-time Director ends on 8 November 2016 on the recommendation of the Nomination  and Remuneration Committee, the Board of Directors of the Company at its meeting held on 12 May 2016 has re-appointed Mr. Rajesh Desai as Whole-time Director designated  as Executive Director for the further period of one year w.e.f. 9 November 2016 subject to approval of shareholders at ensuing  Annual General Meeting of the Company.',  All Independent Directors have declared that they meet the  criteria of Independence as laid down under Section 149(6) of the Companies Act, 2013 and Regulation 16(b) of SEBI (Listing  Obligations and Disclosure Requirements) Regulations, 2015.', Mr. N. B. Desai resigned as a Board Member w.e.f. 1 June 2015 due to his old age and health conditions. The Board placed on  record its sincere appreciation for his valuable guidance and  contribution during his tenure as a Board Member.',  The Board of Directors on the recommendation of the  Nomination & Remuneration Committee had appointed Mr. Milind Sarwate, as an Additional Director of the Company  w.e.f. 29 October 2015.',  In accordance with Section 161 of the Companies Act, 2013, Mr. Milind Sarwate holds office upto the date of the ensuing Annual General Meeting of the Company and being eligible offers his candidature for appointment as Director. The Company has received a notice from a member proposing his appointment as a Director of the Company. His appointment  will be in the category of Non-Executive Independent Director for a term of five years i.e. upto 28 October 2020 and not liable  to retire by rotation. A resolution seeking your approval for his appointment as Director in the category of Non-Executive  Independent Director has been included at Item no. 7 in the Notice of the forthcoming Annual General Meeting of the Company.', 
                                            
                                            ', SUBSIDIARIES, JOINT VENTURES AND ASSOCIATE COMPANIES', 
                                            ', As per Section 129(3) of the Companies Act, 2013 and SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 the Consolidated Financial Statements of the Company and all its subsidiaries for the year ended 31 March 2016 prepared in accordance with International Financial Reporting Standards and Indian Generally Accepted Accounting Principles as permitted by SEBI forms a part of the Annual Report. Further  in terms of the first proviso of Section 129(3) of the Act and Rules 5 and 8(1) of the Companies (Accounts) Rules, 2014, a statement containing the salient features, performance and financial position of the subsidiaries in the prescribed Form  AOC-1 is appended herewith as Annexure I to the Report.', 
                                            
                                            ', During the F.Y. 2015-16', 
                                            ', 
                                                ', Three new step-down subsidiaries were incorporated which are as under:
                                                    ', 
                                                        ', Viso Farmaceutica S.L., Spain', 
                                                        ', Glenmark Specialty S.A.; Switzerland', 
                                                        ', Glenmark Pharmaceuticals Distribution S.R.O.; Czech Republic', 
                                                    ', 
                                                ', 
                                                ', Glenmark Generics Finance S.A., Switzerland got absorbed by way of a side step merger with Glenmark Holding S.A., Switzerland.', 
                                            ', 
                                            ', u"The policy for determining material subsidiaries may be accessed on the Company's website at the link:",  ', http://www.glenmarkpharma.com/UITemplate/PDF/Policy_on_Material_Subsidiary.pdf ', u"The Audited Accounts of the subsidiaries together with its Board's Report and Auditors' Report are available for inspection  of members on any working day at the Corporate Office of the Company between 11 a.m. to 1 p.m.", 
                                            
                                            ', MANAGEMENT DISCUSSION AND ANALYSIS REPORT', 
                                            
                                            ', The Management Discussion and Analysis Report on the operations of the Company, as required under SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015  with the Stock Exchanges is provided in a separate section and forms a part of this report.', 
                                            
                                            ', PARTICULARS OF CONTRACT OR ARRANGEMENTS WITH RELATED PARTIES', 
                                            ', Particulars of contracts or arrangements with related parties referred to in Section 188(1) of the Companies Act, 2013 in the prescribed Form AOC-2, is appended as Annexure II to this report.', 
                                            ', The Company avails professional advisory services from the following Companies/firms in which the Directors are interested:', 						 
                                            ', 
                                                ', Trilegal, a firm in which one of the Directors of the Company is a partner and the Company has paid to them ', Rs.', 1.33 million for availing professional services;', 
                                            ', 
            
                                            ', u"The policy on materiality of related party transactions and dealing with related party transactions may be accessed on the company's website at the link:",  ', http://www.glenmarkpharma.com/UITemplate/PDF/Policy_on_ Related_Party_Transactions_and_its_Materiality_Glenmark.pdf', 
                                            
                                            ', u"AUDITORS AND AUDITORS' REPORT", 
                                            ', Statutory Auditors', 
                                            ', The Auditors, M/s. Walker Chandiok & Co LLP, Chartered Accountants (Firm Registration No. 001076N), were appointed as Auditors in the last (37th) Annual General Meeting for a term of five years i.e., till the conclusion of the 42nd Annual General  Meeting of the Company which was subject to ratification at every Annual General Meeting till the conclusion of 41st Annual General Meeting. A resolution seeking your ratification has been included as Item No. 5 of the Notice convening the Annual General Meeting.', 
                                            ', The Auditors Report does not contain any qualification, reservation or adverse remarks.', 
                                            ', Cost Auditors', 
                                            ', Your Directors, on the recommendation of the Audit Committee  have re-appointed Sevekari, Khare & Associates (Registration No. 000084) as Cost Auditors to audit the cost records of the Company for the Financial Year 2016-2017 at a remuneration of ', Rs.', 1.27 million.', 
                                            
                                            ', Pursuant to Section 148 of the Companies Act, 2013 read with The Companies (Cost Records and Audit) Rules 2014, as amended from time to time, the cost audit records maintained by the Company are required to be audited. In terms of the provisions of the Companies Act, 2013, the remuneration  payable to them is required to be ratified by the Shareholders at the ensuing Annual General Meeting and accordingly, a resolution seeking your ratification has been included as Item No. 6 of the Notice convening the Annual General Meeting. The  Cost Audit Report for the Financial Year 2014-15 has been filed on 29 September 2015.', 
                                            
                                            ', Secretarial Auditor', 
                                            ', The Board had appointed M/s. MARK & Associates Company Secretaries LLP, to conduct Secretarial Audit for the Financial Year 2015-16. The Secretarial Audit Report for the financial year  ended 31 March 2016 is appended herewith as Annexure III to this report. The Secretarial Audit Report does not contain any qualification, reservation or adverse remarks.', 
                                            
                                            ', CHANGES IN CAPITAL STRUCTURE', 
                                            ', Issue of shares on exercise of Employees Stock Options:', 
                                            During the year, we allotted 45,800 Equity Shares of ', Rs.', 1/- each (on pari-passu basis) on the exercise of stock options by the eligible employees of the Company and its subsidiaries under  the 2003 Employee Stock Option Scheme. ', Issue of Shares Pursuant to Merger',  ', 17,803 equity shares of the face value of ', Rs.', 1 each fully paid-up issued to the public shareholders of Glenmark Generics Limited  (GGL) pursuant to the Merger of GGL with the Company.',  ', Issue of Shares on Preferential Basis',  The Company had issued 1,08,00,000 equity shares of the face value of ', Rs.', 1 each fully paid-up to Aranda Investments (Mauritius) Pte Ltd. on a preferential basis pursuant to the provisions of Section 62 of Companies Act, 2013 and other applicable provisions, if any.', 
                                            ', As a result of the above, the outstanding issued, subscribed and paid-up equity shares increased from 27,12,94,553 to 28,21,58,156 shares as at 31 March 2016.', 
                                            
                                            ', Employee Stock Option Scheme ', The information in compliance with Regulation 14 of the Securities and Exchange Board of India (Share Base Employee Benefits) Regulations, 2014 as amended are appended herewith as Annexure IV to this Report.', 
                                            ', No employee was issued Stock Options during the year. As on 31 March 2016, 34,500 options were cancelled and 84,500 options are outstanding. ', 
                                            ', On exercising the convertible options so granted, the paid-up equity share capital of the Company will increase by a like number of shares.', 
                                            ',  Further, the Board of Directors of the Company at its meeting held on 12 May 2016 has approved, subject to the  shareholders' approval and other necessary approvals, a new Scheme 'Glenmark Pharmaceuticals Limited - Employee Stock Options Scheme 2016' ("ESOS 2016") under the Securities  and Exchange Board of India (Share Based Employee Benefits) Regulations, 2014 and other applicable laws, Regulations, etc. for the purposes of granting options to the permanent employees of the Company and its subsidiaries, as applicable. Approval of the shareholders in this regard is being sought at the ensuing Annual General Meeting of the Company.', 
                                                    ', 
                                                 ', 
                                                                            
                                            	 ', 
                                                    ', 
                                                    ', 1', 
                                                    ', 2', 
                                                    ', 3', 
                                                    ', 4', 
                                                    ', 5', 
                                                    ', 6', 
                                                    ', 7', 
                                                    ', 8', 
                                                    ', 9', 
                                                    ', 
                                                  ',                                     
', 
                    ', 
                    
                    ', 
                        ', 
', 
                            ', Statutory Reports', 
', 
                        ', 
                        ', 
', 
                            ', Management Discussion & Analysis', 
                            ', Profile of Directors', 
                            ', u"Board's Report and Relevant Annexures", 
                            ', Report on Corporate Governance', 
', 
                        ', 
                    ', 
                ', 
            ', 
        ', 

        ', 
            ', 
                ', 
                     ', 
                        ', 
                            ', © Copyright 2016 Glenmark', 
                        ', 
                    	', 
                            ', Design by ', Elixir Integrated Brandcomm Pvt Ltd', .', 
                        ', 
                    ', 
                ', 
            ', 
        ', 
        
        ', 
            ', 
        ', 

        ', 
        ', 
        ', 
        ', 
        ', 
        ', 
        ', 
        ', 
        ', 
       
        ', 
    ', 

']